Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
Hamilton
Clive
C
The Australia Institute.
Lokuge
Buddhima
B
Denniss
Richard
R
D001315:Australia; D003132:Commerce / Q000458:organization & administration*; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D007391:International Cooperation; D019982:Organizational Case Studies; D014481:United States